Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,031 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis.
Pope J, Fenlon D, Thompson A, Shea B, Furst D, Wells G, Silman A. Pope J, et al. Among authors: furst d. Cochrane Database Syst Rev. 2000;1998(2):CD000954. doi: 10.1002/14651858.CD000954. Cochrane Database Syst Rev. 2000. PMID: 10796396 Free PMC article. Review.
Cyclofenil for Raynaud's phenomenon in progressive systemic sclerosis.
Pope J, Fenlon D, Thompson A, Shea B, Furst D, Wells G, Silman A. Pope J, et al. Among authors: furst d. Cochrane Database Syst Rev. 2000;1998(2):CD000955. doi: 10.1002/14651858.CD000955. Cochrane Database Syst Rev. 2000. PMID: 10796397 Free PMC article. Review.
Prazosin for Raynaud's phenomenon in progressive systemic sclerosis.
Pope J, Fenlon D, Thompson A, Shea B, Furst D, Wells G, Silman A. Pope J, et al. Among authors: furst d. Cochrane Database Syst Rev. 2000;1998(2):CD000956. doi: 10.1002/14651858.CD000956. Cochrane Database Syst Rev. 2000. PMID: 10796398 Free PMC article. Review.
A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.
Pope JE, Bellamy N, Seibold JR, Baron M, Ellman M, Carette S, Smith CD, Chalmers IM, Hong P, O'Hanlon D, Kaminska E, Markland J, Sibley J, Catoggio L, Furst DE. Pope JE, et al. Among authors: furst de. Arthritis Rheum. 2001 Jun;44(6):1351-8. doi: 10.1002/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I. Arthritis Rheum. 2001. PMID: 11407694 Free article. Clinical Trial.
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E, Rich E, Carpentier P, Molitor J, Seibold JR, Hsu V, Guillevin L, Chatterjee S, Peter HH, Coppock J, Herrick A, Merkel PA, Simms R, Denton CP, Furst D, Nguyen N, Gaitonde M, Black C. Korn JH, et al. Among authors: furst d. Arthritis Rheum. 2004 Dec;50(12):3985-93. doi: 10.1002/art.20676. Arthritis Rheum. 2004. PMID: 15593188 Free article. Clinical Trial.
Scleroderma--developing measures of response.
Furst DE, Khanna D, Mattucci-Cerinic M, Silman AJ, Merkel PA, Foeldvari I; OMERACT 7 Special Interest Group. Furst DE, et al. J Rheumatol. 2005 Dec;32(12):2477-80. J Rheumatol. 2005. PMID: 16331791
Outcome measurements in scleroderma: results from a delphi exercise.
Gazi H, Pope JE, Clements P, Medsger TA, Martin RW, Merkel PA, Kahaleh B, Wollheim FA, Baron M, Csuka ME, Emery P, Belch JF, Hayat S, Lally EV, Korn JH, Czirjak L, Herrick A, Voskuyl AE, Bruehlmann P, Inanc M, Furst DE, Black C, Ellman MH, Moreland LW, Rothfield NF, Hsu V, Mayes M, McKown KM, Krieg T, Siebold JR. Gazi H, et al. J Rheumatol. 2007 Mar;34(3):501-9. Epub 2007 Feb 1. J Rheumatol. 2007. PMID: 17299843
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.
Matucci-Cerinic M, Denton CP, Furst DE, Mayes MD, Hsu VM, Carpentier P, Wigley FM, Black CM, Fessler BJ, Merkel PA, Pope JE, Sweiss NJ, Doyle MK, Hellmich B, Medsger TA Jr, Morganti A, Kramer F, Korn JH, Seibold JR. Matucci-Cerinic M, et al. Among authors: furst de. Ann Rheum Dis. 2011 Jan;70(1):32-8. doi: 10.1136/ard.2010.130658. Epub 2010 Aug 30. Ann Rheum Dis. 2011. PMID: 20805294 Free PMC article. Clinical Trial.
Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.
Sharif R, Fritzler MJ, Mayes MD, Gonzalez EB, McNearney TA, Draeger H, Baron M; Canadian Scleroderma Research Group; Furst DE, Khanna DK, del Junco DJ, Molitor JA, Schiopu E, Phillips K, Seibold JR, Silver RM, Simms RW; GENISOS Study Group; Perry M, Rojo C, Charles J, Zhou X, Agarwal SK, Reveille JD, Assassi S, Arnett FC. Sharif R, et al. Among authors: furst de. J Rheumatol. 2011 Aug;38(8):1622-30. doi: 10.3899/jrheum.110071. Epub 2011 May 15. J Rheumatol. 2011. PMID: 21572159 Free PMC article.
1,031 results